- Release Date: 15/05/24 08:25
- Summary: ARG-007 Reduces Effects of TBI in Preclinical Study
- Price Sensitive: Yes
- Download Document 332.73KB
- Forums
- ASX - By Stock
- AGN
- Ann: ARG-007 Reduces Effects of TBI in Preclinical Study
AGN
argenica therapeutics limited
Add to My Watchlist
1.49%
!
33.0¢

Ann: ARG-007 Reduces Effects of TBI in Preclinical Study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
33.0¢ |
Change
-0.005(1.49%) |
Mkt cap ! $45.60M |
Open | High | Low | Value | Volume |
33.0¢ | 35.5¢ | 32.5¢ | $158.4K | 472.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14299 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 11717 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14299 | 0.330 |
1 | 40500 | 0.320 |
1 | 7936 | 0.315 |
1 | 3225 | 0.310 |
1 | 50000 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 11717 | 1 |
0.350 | 50000 | 1 |
0.355 | 71653 | 2 |
0.370 | 3900 | 1 |
0.375 | 342645 | 1 |
Last trade - 11.11am 12/09/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |